Consolidated EBITDA to Consolidated Interest Expense Ratio. Beginning with the fiscal quarter ending June 30, 2012, the Borrower will not permit the Consolidated EBITDA to Consolidated Interest Expense Ratio as of the last day of any Test Period to be less than 3.0 to 1.0.
Appears in 2 contracts
Samples: Incremental Tranche B Term Loans (LPL Financial Holdings Inc.), Credit Agreement (LPL Investment Holdings Inc.)
Consolidated EBITDA to Consolidated Interest Expense Ratio. Beginning Solely with respect to the Revolving Credit Facility, beginning with the fiscal quarter Test Period ending June 30December 31, 20122014, the Borrower will not permit the Consolidated EBITDA to Consolidated Interest Expense Ratio as of the last day of any Test Period ended on each date set forth below to be less than 3.0 to 1.0.the ratio set forth below opposite such date:
Appears in 1 contract
Samples: Credit Agreement (Amsurg Corp)
Consolidated EBITDA to Consolidated Interest Expense Ratio. Beginning Solely with respect to the Revolving Credit Facility, beginning with the fiscal quarter Test Period ending June 30December 31, 20122014, the Borrower will not permit the Consolidated EBITDA to Consolidated Interest Expense Ratio as of the last day of any Test Period ended on each date set forth below to be less than 3.0 to 1.0.the ratio set forth below opposite such date: Table of Contents
Appears in 1 contract
Samples: Credit Agreement (Amsurg Corp)
Consolidated EBITDA to Consolidated Interest Expense Ratio. Beginning with the fiscal quarter ending June 30, 2012, the The Borrower will not permit the Consolidated EBITDA to Consolidated Interest Expense Ratio as of the last day of for any Test Period beginning with the first Test Period ending after the Closing Date to be less than 3.0 the ratio of 3.5 to 1.01.
Appears in 1 contract
Samples: Credit Agreement